Abstract
Objective
To assess changes associated with nitric oxide (NO) discontinuation in neonates receiving inhalational NO therapy as a treatment for pulmonary hypertension of the neonate (PPHN).
Design
Prospective study.
Setting
A pediatric PICU in a university hospital.
Patients and methods
Ten neonates were included. NO discontinaution was attempted when the oxygenation index fell below 10. The mean NO concentration was 4.9±0.8 ppm. Each infant was studied over three successive 5-min periods and was assigned to either group 1 (NO +1 , NO +2 , NO−) or group 2 (NO +1 , NO−, NO +2 ).
Measurements and results
Postductal transcutaneous PO2 (tcPO2), postductal oxygen saturation with pulse oxymetry (SpO2), systolic and diastolic blood pressure (BP), heart rate (HR), left ventricular shortening fraction (LVSF), cardiac output (CO), and ratio of pulmonary artery time to peak velocity and right ventricular ejection time (TPV/RVET) were similar during the two successive NO+ periods (group 1), thus demonstrating that the measurements were reproducible. NO removal (groups 1 and 2) did not modify systolic or diastolic BP, HR, CO, or LVSF but did induce a significant decline in SpO2, tcPO2 (−25±5%) and TPV/RVET ratio (−25±3%). No reinstitution reversed the effects of NO withdrawal on tcPO2, SpO2 and TPV/RVET ratio (group 2) without any changes in systemic hemodynamics.
Conlusion
The shut-off of lowdose NO induced in each patient a decrease in oxygen delivery that may be due to increased pulmonary vascular resistances and/or redistribution of pulmonary blood flow with ventilation-perfusion mismatching. The optimum weaning-off procedure of inhalational NO remains to be determined.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Roberts JD, Polaner DM, Lang P, Zapol WM (1992) Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:818–819
Kinsella JP, Neish SR, Shaffer E, Abman SH (1992) Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:819–820
Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH (1993) Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses inhaled nitric oxide. J Pediatr 123:103–108
Abman S, SH, Kinsella JP, Shaffer MS, Wilkening RB (1993) Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics 92:606–609
Sellden H, Winberg P, Gustafsson LE, Lundell B, Book K, Frostell CG (1993) Inhalation of nitric oxide reduced pulmonary hypertension after cardiac surgery in a 3.2 kg infant. Anesthesiology 78:577–580
Berner M, Beghetti M, Ricou B, Rouge JC, Pretre R, Friedli B (1993) Relief of severe pulmonary hypertension after closure of a large ventricular septal defect using low-dose inhaled nitric oxide. Intensive Care Med 19:75–77
Haydar A, Malhere T, Mauriat P, Journois D, Pouard P, Denis N, Lefebvre D, Safran D, Vouhe P (1992) Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects. Lancet 340:1545
Kinsella JP, Toews WH, Henry D, Abman SH (1993) Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension. J Pediatr 122:803–806
Gerlach H, Pappert D, Lewandowski K, Rossaint R, Falke KJ (1993) Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 19:443–449
Mercier JC, Dehan M and the Groupe Français Pédiatrique d'Etude du NO (1993) Inhalational nitric oxide (NO) in persistent pulmonary hypertension of the newborn (PPHN). Results of the French multicentric open study. Am J Resp Crit Care Med 149:A545
Kinsella JP, McCurnin DC, clark RH, Lally KP, Null DM Jr (1992) Cardiac performance in ECMO candidates: echocardiographic predictors for ECMO, J Pediatr Surg 27:44–47
Mercier JC, Zupan V, Dehan M, Renaudin MH, Bouchet M, Raveau C (1993) Device to monitor concentration of inhaled nitric oxide. Lancet 342:431–432
Hudson I, Houston A, Aitshison T, Holland B, Turner T (1990) Reproducibiity of measurements of cardiac output in newborn infants with Doppler ultrasound. Arch Dis Child 65:15–19
Evans NJ, Archer LNJ (1990) Postnatal circulatory adaptation in healthy term and preterm neonates. Arch Dis Child 65:24–26
Kitabatake A, Inoue M, Asao, Masuyama T, Tanouchi J, Morita T, Mishima M, Uematsu M, Shimazu T, Mori M, Abe H (1983) Non-invasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation 68:302–309
Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol W (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328:399–405
Buga GM, Griscavage JM, Rogers NE, Ignarro LJ (1993) Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 73:808–812
Kiff RJ, Moss DW, Moncada S (1994) Effect of nitric oxide gas on the generation of nitric oxide by isolated blood vessels: implications for inhalation therapy. Br J Pharmacol 113:496–498
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Françoise, M., Gouyon, J.B. & Mercier, J.C. Hemodynamics and oxygenation changes induced by the discontinuation of low-dose inhalational nitric oxide in newborn infants. Intensive Care Med 22, 477–481 (1996). https://doi.org/10.1007/BF01712171
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01712171